The neurobiology and neurochemistry of bipolar disorder and its different phases are poorly understood. This study investigated metabolite abnormalities in both unmedicated bipolar depression as well as mania using 2D 1 H magnetic resonance spectroscopy imaging (MRSI). MRSI data were obtained from 24 unmedicated bipolar disorder (BP) subjects (12 (hypo)manic (BPM)) and 12 depressed (BPD), and 20 closely matched healthy controls. 2D 1 H MRSI data were collected from a 15-mm axial slice placed along the anterior commissure-posterior commissure (AC-PC) line to measure brain metabolites bilaterally in the thalamus and also the anterior and posterior cingulate cortex (ACC and PCC). Brain Lac/Cr levels were significantly increased in the BP group as a whole compared to healthy controls. Glutamate abnormalities varied across bipolar state as well as brain region: significantly increased Glx/Cr values were found in the left thalamus in BPD, but BPM had decreased Glu/Cr and Glx/Cr levels in the PCC when compared to healthy controls and decreased Glu/Cr levels even when compared to the BPD subjects group. The findings of the study point to state-related abnormalities of oxidative and glutamate metabolism in bipolar disorder.
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Background
Bipolar disorder (BP) is a debilitating mood disorder with unpredictable cycles of depression (BPD) and manic episodes (BPM) interspersed with variable lengths of euthymia. The etiology of bipolar disorder is not clear, although a strong biological basis is suspected due to its hereditary nature. The occurrence of the diametrically opposite mood states of mania and depression is the most striking and perplexing aspect of the illness; therefore, investigating the similarities and differences in the neurobiological basis of the two states is likely to increase the understanding of the etiology of BP. Converging findings from animal and human studies point to the anterior cingulate-striatal-thalamic-amygdala as a putative mood-regulating circuit (MRC) that may be dysfunctional in mood disorders (Anand and Charney, 2000) . A number of investigators have utilized neuroimaging techniques such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) to investigate the pathophysiology of the MRC in BP as well as magnetic resonance spectroscopy (MRS) to investigate neurochemical abnormalities within the MRC. This report focuses on MRS abnormalities in BPD and BPM. (Winsberg et al., 2000; Brambilla et al., 2004; Dager et al., 2004; Gallelli et al., 2005; Frye et al., 2007a) , elevated gray matter lactate (Dager et al., 2004; Stork and Renshaw, 2005) , decreased or unchanged γ-aminobutyric acid (GABA) (Bhagwagar et al., 2007; Kaufman et al., 2009) , and elevated Glx (glutamate+glutamine) concentrations (Dager et al., 2004; Michael et al., 2009; Yüksel and Öngür, 2010) .
31 P MRS studies have reported increased phosphomonester (Kato et al., 1991; Volz et al., 1998; Yildiz et al., 2001; Silverstone et al., 2002 ) levels and decreased phosphocreatinine (Kato et al., 1995; Murashita et al., 2000) 
